BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15386209)

  • 41. Guidelines for devices and choices.
    Everard ML
    J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aerosol delivery devices in the treatment of asthma.
    Hess DR
    Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].
    Sliwiński P; Chazan R; Dąbrowiecki P; Jahnz-Różyk K; Mróz R; Pirożyński M
    Pneumonol Alergol Pol; 2014; 82(3):300-10. PubMed ID: 24793155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are outcomes the same with all dry powder inhalers?
    Thomas M; Williams AE
    Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.
    Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E
    Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Genuair® inhaler: a novel, multidose dry powder inhaler.
    Chrystyn H; Niederlaender C
    Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of dry powder inhalers in COPD.
    Wilson DS; Gillion MS; Rees PJ
    Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhalation steroids, some aspects and ways in the management of asthma.
    Majumdar SP; Kumar TR
    J Indian Med Assoc; 1994 Jul; 92(7):233-4. PubMed ID: 7963605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerosol delivery systems in childhood asthma.
    Chauhan S; Gogtay JA
    Indian J Pediatr; 2001 Sep; 68 Suppl 4():S17-22. PubMed ID: 11980464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy.
    Vidgren M; Paronen P; Vidgren P; Vainio P; Nuutinen J
    Acta Pharm Nord; 1990; 2(1):3-10. PubMed ID: 2340095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Inhalation therapy: techniques and use of devices--main mistakes].
    Voshaar T
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():2-6. PubMed ID: 12593174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paediatric pulmonary drug delivery: considerations in asthma treatment.
    Berger WE
    Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.